Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between

A M Randi1, I Rabinowitz, D J Mancuso

  • 1Howard Hughes Medical Institute, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Insights

Mutations in von Willebrand disease type IIB are linked to specific genetic changes in the von Willebrand factor (vWF). These alterations affect vWF

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Von Willebrand disease (vWD) encompasses various forms of abnormal von Willebrand factor (vWF).
  • Type IIB vWD is characterized by vWF with increased affinity for platelet glycoprotein Ib-IX receptors.

Purpose of the Study:

  • To investigate the molecular genetic basis of von Willebrand disease type IIB.
  • To identify specific mutations responsible for the enhanced vWF-platelet interaction in vWD type IIB.

Main Methods:

  • Analysis of vWF exon 28 using DNA sequencing, allele-specific oligonucleotide hybridization, and restriction endonuclease digestion.
  • Studied 14 patients from 7 unrelated families with vWD type IIB.

Main Results:

  • Identified missense mutations in an 11-amino acid segment within a disulfide loop of vWF domain A1.
  • Common mutations included Arg(543) to Trp and Arg(545) to Cys, with some appearing as new mutations.
  • All identified mutations were C-to-T transitions within CG dinucleotides.

Conclusions:

  • Von Willebrand disease type IIB may result from a limited number of distinct mutations.
  • These mutations are localized to a specific region within a vWF disulfide loop, modulating vWF affinity for platelet receptors.

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K